Wilmington Savings Fund Society FSB Has $5.07 Million Stock Position in Colgate-Palmolive (NYSE:CL)

Wilmington Savings Fund Society FSB raised its position in Colgate-Palmolive (NYSE:CL) by 8.7% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 55,798 shares of the company’s stock after acquiring an additional 4,465 shares during the period. Wilmington Savings Fund Society FSB’s holdings in Colgate-Palmolive were worth $5,073,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently modified their holdings of CL. Chicago Partners Investment Group LLC boosted its stake in Colgate-Palmolive by 16.2% during the 4th quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock valued at $591,000 after purchasing an additional 943 shares during the last quarter. Peak Financial Advisors LLC bought a new position in shares of Colgate-Palmolive in the fourth quarter valued at approximately $1,315,000. Gordian Advisors LLC purchased a new position in shares of Colgate-Palmolive during the third quarter valued at approximately $602,000. Carrera Capital Advisors grew its holdings in Colgate-Palmolive by 23.1% during the third quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock worth $4,066,000 after buying an additional 7,353 shares in the last quarter. Finally, Fiduciary Alliance LLC purchased a new stake in Colgate-Palmolive in the 4th quarter valued at $4,066,000. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 1.3 %

NYSE CL opened at $86.81 on Friday. The company has a quick ratio of 0.26, a current ratio of 0.41 and a debt-to-equity ratio of 9.46. The stock’s 50-day simple moving average is $90.36 and its two-hundred day simple moving average is $96.76. Colgate-Palmolive has a twelve month low of $82.68 and a twelve month high of $109.30. The company has a market capitalization of $70.93 billion, a price-to-earnings ratio of 24.66, a PEG ratio of 4.12 and a beta of 0.44.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period last year, the business posted $0.87 earnings per share. Research analysts forecast that Colgate-Palmolive will post 3.73 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be given a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.30%. Colgate-Palmolive’s payout ratio is currently 56.82%.

Analysts Set New Price Targets

A number of brokerages have issued reports on CL. Barclays reduced their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research report on Friday, January 17th. JPMorgan Chase & Co. reduced their target price on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a report on Monday, February 3rd. Morgan Stanley dropped their price target on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a report on Monday, February 3rd. UBS Group reduced their price objective on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research note on Monday, February 3rd. Finally, Royal Bank of Canada reiterated a “sector perform” rating and set a $101.00 target price on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $101.16.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.